Defining incidence of fibrolamellar carcinoma through computational analysis of multiple data types
Timeframe: 2021 – 2022 Investigators: John Gordan, MD, PhD, Assistant Professor, Department of Medicine, UCSF; Travis Zack, MD, UCSF; and Kurt Losert, FCF Goal: Develop updated estimate for US national incidence of FLC The most cited study of national incidence of FLC, using data from the National Cancer Institute’s Surveillance, Epidemiology, and End Results (SEER) …